Standard Lancets Market
1 Study Coverage
1.1 Standard Lancets Product Introduction
1.2 Market by Type
1.2.1 Global Standard Lancets Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Needle
1.2.3 Blade
1.3 Market by Application
1.3.1 Global Standard Lancets Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Homecare Settings
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Standard Lancets Sales Estimates and Forecasts 2017-2028
2.2 Global Standard Lancets Revenue Estimates and Forecasts 2017-2028
2.3 Global Standard Lancets Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Standard Lancets Sales by Region
2.4.1 Global Standard Lancets Sales by Region (2017-2022)
2.4.2 Global Sales Standard Lancets by Region (2023-2028)
2.5 Global Standard Lancets Revenue by Region
2.5.1 Global Standard Lancets Revenue by Region (2017-2022)
2.5.2 Global Standard Lancets Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Standard Lancets Sales by Manufacturers
3.1.1 Global Top Standard Lancets Manufacturers by Sales (2017-2022)
3.1.2 Global Standard Lancets Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Standard Lancets in 2021
3.2 Global Standard Lancets Revenue by Manufacturers
3.2.1 Global Standard Lancets Revenue by Manufacturers (2017-2022)
3.2.2 Global Standard Lancets Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Standard Lancets Revenue in 2021
3.3 Global Standard Lancets Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Standard Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Standard Lancets Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Standard Lancets Sales by Type
4.1.1 Global Standard Lancets Historical Sales by Type (2017-2022)
4.1.2 Global Standard Lancets Forecasted Sales by Type (2023-2028)
4.1.3 Global Standard Lancets Sales Market Share by Type (2017-2028)
4.2 Global Standard Lancets Revenue by Type
4.2.1 Global Standard Lancets Historical Revenue by Type (2017-2022)
4.2.2 Global Standard Lancets Forecasted Revenue by Type (2023-2028)
4.2.3 Global Standard Lancets Revenue Market Share by Type (2017-2028)
4.3 Global Standard Lancets Price by Type
4.3.1 Global Standard Lancets Price by Type (2017-2022)
4.3.2 Global Standard Lancets Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Standard Lancets Sales by Application
5.1.1 Global Standard Lancets Historical Sales by Application (2017-2022)
5.1.2 Global Standard Lancets Forecasted Sales by Application (2023-2028)
5.1.3 Global Standard Lancets Sales Market Share by Application (2017-2028)
5.2 Global Standard Lancets Revenue by Application
5.2.1 Global Standard Lancets Historical Revenue by Application (2017-2022)
5.2.2 Global Standard Lancets Forecasted Revenue by Application (2023-2028)
5.2.3 Global Standard Lancets Revenue Market Share by Application (2017-2028)
5.3 Global Standard Lancets Price by Application
5.3.1 Global Standard Lancets Price by Application (2017-2022)
5.3.2 Global Standard Lancets Price Forecast by Application (2023-2028)
6 North America
6.1 North America Standard Lancets Market Size by Type
6.1.1 North America Standard Lancets Sales by Type (2017-2028)
6.1.2 North America Standard Lancets Revenue by Type (2017-2028)
6.2 North America Standard Lancets Market Size by Application
6.2.1 North America Standard Lancets Sales by Application (2017-2028)
6.2.2 North America Standard Lancets Revenue by Application (2017-2028)
6.3 North America Standard Lancets Market Size by Country
6.3.1 North America Standard Lancets Sales by Country (2017-2028)
6.3.2 North America Standard Lancets Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Standard Lancets Market Size by Type
7.1.1 Europe Standard Lancets Sales by Type (2017-2028)
7.1.2 Europe Standard Lancets Revenue by Type (2017-2028)
7.2 Europe Standard Lancets Market Size by Application
7.2.1 Europe Standard Lancets Sales by Application (2017-2028)
7.2.2 Europe Standard Lancets Revenue by Application (2017-2028)
7.3 Europe Standard Lancets Market Size by Country
7.3.1 Europe Standard Lancets Sales by Country (2017-2028)
7.3.2 Europe Standard Lancets Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Standard Lancets Market Size by Type
8.1.1 Asia Pacific Standard Lancets Sales by Type (2017-2028)
8.1.2 Asia Pacific Standard Lancets Revenue by Type (2017-2028)
8.2 Asia Pacific Standard Lancets Market Size by Application
8.2.1 Asia Pacific Standard Lancets Sales by Application (2017-2028)
8.2.2 Asia Pacific Standard Lancets Revenue by Application (2017-2028)
8.3 Asia Pacific Standard Lancets Market Size by Region
8.3.1 Asia Pacific Standard Lancets Sales by Region (2017-2028)
8.3.2 Asia Pacific Standard Lancets Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Standard Lancets Market Size by Type
9.1.1 Latin America Standard Lancets Sales by Type (2017-2028)
9.1.2 Latin America Standard Lancets Revenue by Type (2017-2028)
9.2 Latin America Standard Lancets Market Size by Application
9.2.1 Latin America Standard Lancets Sales by Application (2017-2028)
9.2.2 Latin America Standard Lancets Revenue by Application (2017-2028)
9.3 Latin America Standard Lancets Market Size by Country
9.3.1 Latin America Standard Lancets Sales by Country (2017-2028)
9.3.2 Latin America Standard Lancets Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Standard Lancets Market Size by Type
10.1.1 Middle East and Africa Standard Lancets Sales by Type (2017-2028)
10.1.2 Middle East and Africa Standard Lancets Revenue by Type (2017-2028)
10.2 Middle East and Africa Standard Lancets Market Size by Application
10.2.1 Middle East and Africa Standard Lancets Sales by Application (2017-2028)
10.2.2 Middle East and Africa Standard Lancets Revenue by Application (2017-2028)
10.3 Middle East and Africa Standard Lancets Market Size by Country
10.3.1 Middle East and Africa Standard Lancets Sales by Country (2017-2028)
10.3.2 Middle East and Africa Standard Lancets Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Lifescan
11.2.1 Lifescan Corporation Information
11.2.2 Lifescan Overview
11.2.3 Lifescan Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Lifescan Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lifescan Recent Developments
11.3 BD
11.3.1 BD Corporation Information
11.3.2 BD Overview
11.3.3 BD Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 BD Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BD Recent Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Overview
11.4.3 Bayer Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bayer Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bayer Recent Developments
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Overview
11.5.3 Abbott Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Abbott Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abbott Recent Developments
11.6 B. Braun
11.6.1 B. Braun Corporation Information
11.6.2 B. Braun Overview
11.6.3 B. Braun Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 B. Braun Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 B. Braun Recent Developments
11.7 ARKRAY
11.7.1 ARKRAY Corporation Information
11.7.2 ARKRAY Overview
11.7.3 ARKRAY Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 ARKRAY Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ARKRAY Recent Developments
11.8 Terumo
11.8.1 Terumo Corporation Information
11.8.2 Terumo Overview
11.8.3 Terumo Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Terumo Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Terumo Recent Developments
11.9 I-SENS
11.9.1 I-SENS Corporation Information
11.9.2 I-SENS Overview
11.9.3 I-SENS Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 I-SENS Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 I-SENS Recent Developments
11.10 Nipro
11.10.1 Nipro Corporation Information
11.10.2 Nipro Overview
11.10.3 Nipro Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Nipro Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nipro Recent Developments
11.11 Omron
11.11.1 Omron Corporation Information
11.11.2 Omron Overview
11.11.3 Omron Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Omron Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Omron Recent Developments
11.12 Infopia
11.12.1 Infopia Corporation Information
11.12.2 Infopia Overview
11.12.3 Infopia Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Infopia Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Infopia Recent Developments
11.13 AgaMatrix
11.13.1 AgaMatrix Corporation Information
11.13.2 AgaMatrix Overview
11.13.3 AgaMatrix Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 AgaMatrix Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 AgaMatrix Recent Developments
11.14 Smiths Medical
11.14.1 Smiths Medical Corporation Information
11.14.2 Smiths Medical Overview
11.14.3 Smiths Medical Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Smiths Medical Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Smiths Medical Recent Developments
11.15 Sarstedt
11.15.1 Sarstedt Corporation Information
11.15.2 Sarstedt Overview
11.15.3 Sarstedt Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Sarstedt Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Sarstedt Recent Developments
11.16 SANNUO
11.16.1 SANNUO Corporation Information
11.16.2 SANNUO Overview
11.16.3 SANNUO Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 SANNUO Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 SANNUO Recent Developments
11.17 Yicheng
11.17.1 Yicheng Corporation Information
11.17.2 Yicheng Overview
11.17.3 Yicheng Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Yicheng Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Yicheng Recent Developments
11.18 Yuwell
11.18.1 Yuwell Corporation Information
11.18.2 Yuwell Overview
11.18.3 Yuwell Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Yuwell Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Yuwell Recent Developments
11.19 Greiner Bio One
11.19.1 Greiner Bio One Corporation Information
11.19.2 Greiner Bio One Overview
11.19.3 Greiner Bio One Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Greiner Bio One Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Greiner Bio One Recent Developments
11.20 Edan
11.20.1 Edan Corporation Information
11.20.2 Edan Overview
11.20.3 Edan Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Edan Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Edan Recent Developments
11.21 Narang Medical
11.21.1 Narang Medical Corporation Information
11.21.2 Narang Medical Overview
11.21.3 Narang Medical Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Narang Medical Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Narang Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Standard Lancets Industry Chain Analysis
12.2 Standard Lancets Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Standard Lancets Production Mode & Process
12.4 Standard Lancets Sales and Marketing
12.4.1 Standard Lancets Sales Channels
12.4.2 Standard Lancets Distributors
12.5 Standard Lancets Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Standard Lancets Industry Trends
13.2 Standard Lancets Market Drivers
13.3 Standard Lancets Market Challenges
13.4 Standard Lancets Market Restraints
14 Key Findings in The Global Standard Lancets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Standard Lancets Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Needle
Table 3. Major Manufacturers of Blade
Table 4. Global Standard Lancets Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Standard Lancets Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Standard Lancets Sales by Region (2017-2022) & (K Units)
Table 7. Global Standard Lancets Sales Market Share by Region (2017-2022)
Table 8. Global Standard Lancets Sales by Region (2023-2028) & (K Units)
Table 9. Global Standard Lancets Sales Market Share by Region (2023-2028)
Table 10. Global Standard Lancets Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Standard Lancets Revenue Market Share by Region (2017-2022)
Table 12. Global Standard Lancets Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Standard Lancets Revenue Market Share by Region (2023-2028)
Table 14. Global Standard Lancets Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Standard Lancets Sales Share by Manufacturers (2017-2022)
Table 16. Global Standard Lancets Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Standard Lancets Revenue Share by Manufacturers (2017-2022)
Table 18. Standard Lancets Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Standard Lancets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Standard Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Standard Lancets as of 2021)
Table 21. Standard Lancets Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Standard Lancets Product Offered
Table 23. Date of Manufacturers Enter into Standard Lancets Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Standard Lancets Sales by Type (2017-2022) & (K Units)
Table 26. Global Standard Lancets Sales by Type (2023-2028) & (K Units)
Table 27. Global Standard Lancets Sales Share by Type (2017-2022)
Table 28. Global Standard Lancets Sales Share by Type (2023-2028)
Table 29. Global Standard Lancets Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Standard Lancets Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Standard Lancets Revenue Share by Type (2017-2022)
Table 32. Global Standard Lancets Revenue Share by Type (2023-2028)
Table 33. Standard Lancets Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Standard Lancets Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Standard Lancets Sales by Application (2017-2022) & (K Units)
Table 36. Global Standard Lancets Sales by Application (2023-2028) & (K Units)
Table 37. Global Standard Lancets Sales Share by Application (2017-2022)
Table 38. Global Standard Lancets Sales Share by Application (2023-2028)
Table 39. Global Standard Lancets Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Standard Lancets Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Standard Lancets Revenue Share by Application (2017-2022)
Table 42. Global Standard Lancets Revenue Share by Application (2023-2028)
Table 43. Standard Lancets Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Standard Lancets Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Standard Lancets Sales by Type (2017-2022) & (K Units)
Table 46. North America Standard Lancets Sales by Type (2023-2028) & (K Units)
Table 47. North America Standard Lancets Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Standard Lancets Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Standard Lancets Sales by Application (2017-2022) & (K Units)
Table 50. North America Standard Lancets Sales by Application (2023-2028) & (K Units)
Table 51. North America Standard Lancets Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Standard Lancets Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Standard Lancets Sales by Country (2017-2022) & (K Units)
Table 54. North America Standard Lancets Sales by Country (2023-2028) & (K Units)
Table 55. North America Standard Lancets Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Standard Lancets Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Standard Lancets Sales by Type (2017-2022) & (K Units)
Table 58. Europe Standard Lancets Sales by Type (2023-2028) & (K Units)
Table 59. Europe Standard Lancets Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Standard Lancets Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Standard Lancets Sales by Application (2017-2022) & (K Units)
Table 62. Europe Standard Lancets Sales by Application (2023-2028) & (K Units)
Table 63. Europe Standard Lancets Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Standard Lancets Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Standard Lancets Sales by Country (2017-2022) & (K Units)
Table 66. Europe Standard Lancets Sales by Country (2023-2028) & (K Units)
Table 67. Europe Standard Lancets Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Standard Lancets Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Standard Lancets Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Standard Lancets Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Standard Lancets Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Standard Lancets Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Standard Lancets Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Standard Lancets Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Standard Lancets Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Standard Lancets Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Standard Lancets Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Standard Lancets Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Standard Lancets Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Standard Lancets Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Standard Lancets Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Standard Lancets Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Standard Lancets Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Standard Lancets Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Standard Lancets Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Standard Lancets Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Standard Lancets Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Standard Lancets Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Standard Lancets Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Standard Lancets Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Standard Lancets Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Standard Lancets Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Standard Lancets Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Standard Lancets Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Standard Lancets Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Standard Lancets Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Standard Lancets Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Standard Lancets Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Standard Lancets Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Standard Lancets Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Standard Lancets Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Standard Lancets Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Standard Lancets Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Standard Lancets Revenue by Country (2023-2028) & (US$ Million)
Table 105. Roche Corporation Information
Table 106. Roche Description and Major Businesses
Table 107. Roche Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Roche Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Roche Recent Developments
Table 110. Lifescan Corporation Information
Table 111. Lifescan Description and Major Businesses
Table 112. Lifescan Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Lifescan Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Lifescan Recent Developments
Table 115. BD Corporation Information
Table 116. BD Description and Major Businesses
Table 117. BD Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. BD Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. BD Recent Developments
Table 120. Bayer Corporation Information
Table 121. Bayer Description and Major Businesses
Table 122. Bayer Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Bayer Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Bayer Recent Developments
Table 125. Abbott Corporation Information
Table 126. Abbott Description and Major Businesses
Table 127. Abbott Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Abbott Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Abbott Recent Developments
Table 130. B. Braun Corporation Information
Table 131. B. Braun Description and Major Businesses
Table 132. B. Braun Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. B. Braun Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. B. Braun Recent Developments
Table 135. ARKRAY Corporation Information
Table 136. ARKRAY Description and Major Businesses
Table 137. ARKRAY Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. ARKRAY Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. ARKRAY Recent Developments
Table 140. Terumo Corporation Information
Table 141. Terumo Description and Major Businesses
Table 142. Terumo Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Terumo Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Terumo Recent Developments
Table 145. I-SENS Corporation Information
Table 146. I-SENS Description and Major Businesses
Table 147. I-SENS Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. I-SENS Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. I-SENS Recent Developments
Table 150. Nipro Corporation Information
Table 151. Nipro Description and Major Businesses
Table 152. Nipro Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Nipro Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Nipro Recent Developments
Table 155. Omron Corporation Information
Table 156. Omron Description and Major Businesses
Table 157. Omron Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Omron Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Omron Recent Developments
Table 160. Infopia Corporation Information
Table 161. Infopia Description and Major Businesses
Table 162. Infopia Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Infopia Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Infopia Recent Developments
Table 165. AgaMatrix Corporation Information
Table 166. AgaMatrix Description and Major Businesses
Table 167. AgaMatrix Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. AgaMatrix Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. AgaMatrix Recent Developments
Table 170. Smiths Medical Corporation Information
Table 171. Smiths Medical Description and Major Businesses
Table 172. Smiths Medical Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 173. Smiths Medical Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Smiths Medical Recent Developments
Table 175. Sarstedt Corporation Information
Table 176. Sarstedt Description and Major Businesses
Table 177. Sarstedt Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 178. Sarstedt Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Sarstedt Recent Developments
Table 180. SANNUO Corporation Information
Table 181. SANNUO Description and Major Businesses
Table 182. SANNUO Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 183. SANNUO Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. SANNUO Recent Developments
Table 185. Yicheng Corporation Information
Table 186. Yicheng Description and Major Businesses
Table 187. Yicheng Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 188. Yicheng Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Yicheng Recent Developments
Table 190. Yuwell Corporation Information
Table 191. Yuwell Description and Major Businesses
Table 192. Yuwell Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 193. Yuwell Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Yuwell Recent Developments
Table 195. Greiner Bio One Corporation Information
Table 196. Greiner Bio One Description and Major Businesses
Table 197. Greiner Bio One Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 198. Greiner Bio One Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Greiner Bio One Recent Developments
Table 200. Edan Corporation Information
Table 201. Edan Description and Major Businesses
Table 202. Edan Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 203. Edan Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 204. Edan Recent Developments
Table 205. Narang Medical Corporation Information
Table 206. Narang Medical Description and Major Businesses
Table 207. Narang Medical Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 208. Narang Medical Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications
Table 209. Narang Medical Recent Developments
Table 210. Key Raw Materials Lists
Table 211. Raw Materials Key Suppliers Lists
Table 212. Standard Lancets Distributors List
Table 213. Standard Lancets Customers List
Table 214. Standard Lancets Market Trends
Table 215. Standard Lancets Market Drivers
Table 216. Standard Lancets Market Challenges
Table 217. Standard Lancets Market Restraints
Table 218. Research Programs/Design for This Report
Table 219. Key Data Information from Secondary Sources
Table 220. Key Data Information from Primary Sources
List of Figures
Figure 1. Standard Lancets Product Picture
Figure 3. Global Standard Lancets Market Share by Type in 2021 & 2028
Figure 3. Needle Product Picture
Figure 4. Blade Product Picture
Figure 5. Global Standard Lancets Market Share by Application in 2021 & 2028
Figure 6. Hospitals and Clinics
Figure 7. Homecare Settings
Figure 8. Others
Figure 9. Standard Lancets Report Years Considered
Figure 10. Global Standard Lancets Sales 2017-2028 (K Units)
Figure 11. Global Standard Lancets Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Standard Lancets Revenue 2017-2028 (US$ Million)
Figure 13. Global Standard Lancets Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Standard Lancets Sales Market Share by Region (2017-2022)
Figure 15. Global Standard Lancets Sales Market Share by Region (2023-2028)
Figure 16. North America Standard Lancets Sales YoY (2017-2028) & (K Units)
Figure 17. North America Standard Lancets Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Standard Lancets Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Standard Lancets Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Standard Lancets Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Standard Lancets Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Standard Lancets Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Standard Lancets Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Standard Lancets Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Standard Lancets Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Standard Lancets Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Standard Lancets in the World: Market Share by Standard Lancets Revenue in 2021
Figure 28. Global Standard Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Standard Lancets Sales Market Share by Type (2017-2028)
Figure 30. Global Standard Lancets Revenue Market Share by Type (2017-2028)
Figure 31. Global Standard Lancets Sales Market Share by Application (2017-2028)
Figure 32. Global Standard Lancets Revenue Market Share by Application (2017-2028)
Figure 33. North America Standard Lancets Sales Market Share by Type (2017-2028)
Figure 34. North America Standard Lancets Revenue Market Share by Type (2017-2028)
Figure 35. North America Standard Lancets Sales Market Share by Application (2017-2028)
Figure 36. North America Standard Lancets Revenue Market Share by Application (2017-2028)
Figure 37. North America Standard Lancets Sales Share by Country (2017-2028)
Figure 38. North America Standard Lancets Revenue Share by Country (2017-2028)
Figure 39. U.S. Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Standard Lancets Sales Market Share by Type (2017-2028)
Figure 42. Europe Standard Lancets Revenue Market Share by Type (2017-2028)
Figure 43. Europe Standard Lancets Sales Market Share by Application (2017-2028)
Figure 44. Europe Standard Lancets Revenue Market Share by Application (2017-2028)
Figure 45. Europe Standard Lancets Sales Share by Country (2017-2028)
Figure 46. Europe Standard Lancets Revenue Share by Country (2017-2028)
Figure 47. Germany Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 48. France Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Standard Lancets Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Standard Lancets Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Standard Lancets Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Standard Lancets Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Standard Lancets Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Standard Lancets Revenue Share by Region (2017-2028)
Figure 58. China Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 61. India Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Standard Lancets Sales Market Share by Type (2017-2028)
Figure 69. Latin America Standard Lancets Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Standard Lancets Sales Market Share by Application (2017-2028)
Figure 71. Latin America Standard Lancets Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Standard Lancets Sales Share by Country (2017-2028)
Figure 73. Latin America Standard Lancets Revenue Share by Country (2017-2028)
Figure 74. Mexico Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Standard Lancets Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Standard Lancets Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Standard Lancets Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Standard Lancets Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Standard Lancets Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Standard Lancets Revenue Share by Country (2017-2028)
Figure 83. Turkey Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Standard Lancets Revenue (2017-2028) & (US$ Million)
Figure 86. Standard Lancets Value Chain
Figure 87. Standard Lancets Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Industry Market Size
